Paul Olivo

Paul Olivo is a board certified internist and physician scientist with extensive experience in biotechnology and in vitro diagnostics. He holds multiple patents in the field of diagnostic virology and has developed multiple FDA-cleared diagnostic tests.His technology was instrumental in building Diagnostic Hybrids, Inc. to $40M in sales before it was acquired by Quidel Corporation (San Diego, CA) for $130M in 2010. Dr. Olivo was also President and CSO of Apath, LLC, a St. Louis start-up company that held key hepatitis C IP. Under Dr. Olivo’s leadership, Apath generated over $20M in licensing income and secured $12M in federal grants to support its antiviral drug discovery program. Most recently, Dr. Olivo was Senior Medical Director at Quidel. Presently, he is a senior entrepreneur-in-residence at Biogenerator and a Director at Common Place Holdings.